BRADLEY FOSTER & SARGENT INC/CT – Regeneron Pharmaceuticals, Inc. Transaction History
BRADLEY FOSTER & SARGENT INC/CT portfolio value:
$1.35M
portfolio value
BRADLEY FOSTER & SARGENT INC/CT quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 191K | $688.87 | 1.96K | |
| Q2 2022 | share | Increase | +66.05% | 780 shares | 335K | $591.13 | 1.96K |
| Q1 2022 | share | Increase | +106.83% | 610 shares | 464K | $698.42 | 1.18K |
| Q4 2021 | share | 0.00% | 0 shares | 15K | $642.51 | 571 | |
| Q3 2021 | share | Increase | +12.18% | 62 shares | 62K | $605.18 | 571 |
| Q2 2021 | share | Increase | +0.99% | 5 shares | 46K | $558.54 | 509 |
| Q1 2021 | share | Decrease | -34.38% | -264 shares | -133K | $473.14 | 504 |
| Q4 2020 | share | Increase | +6.96% | 50 shares | -31K | $483.11 | 768 |
| Q3 2020 | share | Increase | +1.99% | 14 shares | 58K | $559.78 | 718 |
| Q1 2020 | share | Decrease | -6.63% | -50 shares | 61K | $488.29 | 704 |
| Q4 2019 | share | 0.00% | 0 shares | 74K | $375.48 | 754 | |
| Q3 2019 | share | 0.00% | 0 shares | -27K | $277.4 | 754 | |
| Q2 2019 | share | Decrease | -16.59% | -150 shares | -135K | $313 | 754 |
| Q1 2019 | share | 0.00% | 0 shares | 33K | $410.62 | 904 | |
| Q4 2018 | share | 0.00% | 0 shares | -27K | $373.5 | 904 | |
| Q3 2018 | share | Increase | +0.44% | 4 shares | 55K | $404.04 | 904 |
| Q2 2018 | share | Decrease | -3.12% | -29 shares | -10K | $344.99 | 900 |
| Q1 2018 | share | 0.00% | 0 shares | -29K | $344.36 | 929 | |
| Q4 2017 | share | Decrease | -3.83% | -37 shares | -83K | $375.96 | 929 |
| Q3 2017 | share | Increase | +3.98% | 37 shares | -24K | $447.12 | 966 |
| Q2 2017 | share | Increase | +3.22% | 29 shares | 107K | $491.14 | 929 |
| Q1 2017 | share | Increase | 0.00% | 900 shares | 349K | $387.51 | 900 |